Latest treating cancer Stories

2012-02-10 15:28:09

A research group in the Faculty of Medicine & Dentistry at the University of Alberta is hoping its latest discovery could one day be used to develop new therapies that target certain types of cancers. The discovery by Mark Glover, his graduate student Zahra Havali-Shahriari and post-doctoral fellow Nicolas Coquelle has shed light on what happens in cells when DNA is damaged. They solved the structure of a DNA repair enzyme called polynucleotide kinase/phosphatase, or PNKP. This allows...

2011-06-08 06:51:07

(Ivanhoe Newswire) "“ Colorectal cancer is the third most commonly diagnosed cancer in the Unites States, and the third leading cause of cancer death. It develops in the colon and rectum, usually as a result of polyps, which are abnormal growths of tissue that extend from mucous membranes in the lower gastrointestinal tract. The most common treatments for this cancer are surgery and chemotherapy. However, chemotherapy can have many life threatening side effects. Now researchers from...

2011-05-24 23:00:09

Clinical trials for a new bladder cancer therapy show promising interim results. Lead researcher Alvaro Morales says that the breakthrough using the drug Urocidin follows thirty years of his research in this important area. "I am optimistic about the results of the trial," says Dr. Morales, professor emeritus in the Department of Urology at Queen's University and director of the Queen's University Centre for Applied Urological Research. "Positive results in the next phase of trials will move...

2011-04-29 14:02:11

Use of chemical systems biology may represent the future of drug discovery Researchers at the University of California, San Diego and Hunter College of the City University of New York (CUNY) have identified potential human molecular targets of the anti-HIV drug Nelfinavir, which may explain why the drug is also effective as a cancer therapy. Their study will be published in the online edition of PLoS Computational Biology on April 28. Nelfinivir is a protease inhibitor that prevents...

2011-04-25 07:00:00

Fear of nausea a significant issue and often not discussed with healthcare providers CALIFON, NJ, April 25 /PRNewswire/ - PediatRx, Inc. (OTCBB: PEDX) today commented on studies which reveal that chemotherapy-induced nausea and vomiting is one of the most feared of all chemotherapy-related side effects.(1-9 )The fear of nausea and subsequent vomiting is many times so significant that patients can develop a condition known as 'anticipatory' nausea, where the patient becomes nauseous...

2011-03-07 07:59:00

BOZEN, Sud-Tirol, Italy, March 7, 2011 /PRNewswire/ -- Health Robotics today announced the completion of its initial research, development, and factory-testing activities for its next-generation Cancer Therapy Robot, i.v.STATION ONCO, and its unveiling at the European Association of Hospital Pharmacists (EAHP) in Vienna on 1 April 2011, including its new overpowering features: four times faster, five times smaller, and three times less expensive than some of the other Sterile Compounding...

2011-02-14 15:22:47

One of the most important genes in the human genome is called p53 and its function is to suppress tumours, according to Roger Leng, a researcher in the Faculty of Medicine & Dentistry. Leng has discovered the mechanism by which p53 is inactivated in cancerous cells, allowing tumors to grow. "Successful completion of the proposed experiments could lead to novel anti-cancer therapies that could potentially improve the prognosis for cancer patients and reduce the public health burden from...

2011-02-14 06:30:00

CALGARY, Feb. 14 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced preliminary results from a U.S. Phase 2 clinical trial  (REO 017) using intravenous administration of REOLYSIN((R)) in combination with gemcitabine (Gemzar((R))) in patients with advanced pancreatic cancer. The trial is being conducted at the Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio (CTRC). The Principal...

Word of the Day
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'